This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.
Testing the association between copy number variation 98 arm-level results and 5 clinical features across 454 patients, 158 significant findings detected with Q value < 0.25.
-
Amp Peak 1(1p35.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 2(1p34.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 3(1p22.3) cnv correlated to 'AGE'.
-
Amp Peak 4(1q21.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 5(1q22) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 7(2p23.2) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 8(2q13) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 9(3p25.1) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 10(3p14.1) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 11(3q26.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 12(3q26.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 13(4p16.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 14(5p15.33) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 15(5q35.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 16(6p24.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 17(6q25.1) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 19(8p11.21) cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 20(8q24.21) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 21(8q24.21) cnv correlated to 'HISTOLOGICAL.TYPE' and 'COMPLETENESS.OF.RESECTION'.
-
Amp Peak 22(9p24.2) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 23(9q34.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 25(11p11.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 26(11q13.2) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 27(12p12.1) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 28(12q13.11) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 29(12q13.2) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 30(13q34) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 31(14q24.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 32(14q32.33) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 33(16p11.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 34(17q11.2) cnv correlated to 'AGE', 'HISTOLOGICAL.TYPE', and 'COMPLETENESS.OF.RESECTION'.
-
Amp Peak 35(17q12) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 36(17q25.1) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 37(18p11.31) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 38(18q11.2) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Amp Peak 39(19p13.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 40(19p13.11) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 41(19q12) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 42(20p13) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 43(20q11.21) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 44(20q13.12) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 45(20q13.33) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Amp Peak 46(22q12.2) cnv correlated to 'HISTOLOGICAL.TYPE' and 'COMPLETENESS.OF.RESECTION'.
-
Amp Peak 48(Xq28) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 1(1p36.21) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 2(1p36.11) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 5(2q22.1) cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 7(3p14.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 8(3q13.31) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 9(4p16.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 10(4p15.31) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 11(4q22.1) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 12(4q34.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 13(5q11.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 14(6q26) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 15(7p22.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 16(7q11.22) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 17(7q31.1) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 18(7q36.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 19(8p23.2) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 20(9p23) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 21(9q34.11) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 22(10q23.31) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 23(11p15.5) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 24(11q14.1) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 25(11q25) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 26(12q23.1) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 27(12q24.33) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 28(13q11) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 29(13q14.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 30(14q13.1) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 31(15q15.1) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 32(15q23) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 33(16p13.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 34(16q21) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 35(16q23.1) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 36(17p13.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 37(17p12) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 38(17p11.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 39(17q11.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 40(17q21.2) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 41(18q23) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 42(19p13.3) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 43(19p12) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 44(19q13.43) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 45(20p12.1) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 46(22q11.1) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 47(22q12.1) cnv correlated to 'HISTOLOGICAL.TYPE'.
-
Del Peak 48(22q13.31) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 49(22q13.32) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
Del Peak 50(Xp21.1) cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
Clinical Features |
Time to Death |
AGE |
HISTOLOGICAL TYPE |
RADIATIONS RADIATION REGIMENINDICATION |
COMPLETENESS OF RESECTION |
||
nCNV (%) | nWild-Type | logrank test | t-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | |
Amp Peak 34(17q11 2) | 0 (0%) | 400 |
0.0426 (1.00) |
0.000348 (0.118) |
1.35e-16 (6.2e-14) |
0.874 (1.00) |
0.000427 (0.144) |
Amp Peak 1(1p35 2) | 0 (0%) | 410 |
0.823 (1.00) |
0.000141 (0.0492) |
2.03e-12 (8.8e-10) |
1 (1.00) |
0.876 (1.00) |
Amp Peak 2(1p34 2) | 0 (0%) | 399 |
0.705 (1.00) |
3.48e-05 (0.0126) |
3.96e-17 (1.82e-14) |
0.347 (1.00) |
0.129 (1.00) |
Amp Peak 4(1q21 3) | 0 (0%) | 253 |
0.133 (1.00) |
1.99e-06 (0.000766) |
0.000332 (0.114) |
0.535 (1.00) |
0.542 (1.00) |
Amp Peak 5(1q22) | 0 (0%) | 241 |
0.0278 (1.00) |
9.36e-08 (3.77e-05) |
1.38e-06 (0.00053) |
0.471 (1.00) |
0.317 (1.00) |
Amp Peak 8(2q13) | 0 (0%) | 362 |
0.0235 (1.00) |
0.000122 (0.0429) |
6.05e-16 (2.75e-13) |
0.799 (1.00) |
0.199 (1.00) |
Amp Peak 9(3p25 1) | 0 (0%) | 391 |
0.487 (1.00) |
0.000132 (0.046) |
1.69e-09 (7.07e-07) |
0.103 (1.00) |
0.864 (1.00) |
Amp Peak 11(3q26 2) | 0 (0%) | 320 |
0.19 (1.00) |
4.28e-10 (1.82e-07) |
2.49e-24 (1.2e-21) |
0.145 (1.00) |
0.199 (1.00) |
Amp Peak 12(3q26 2) | 0 (0%) | 328 |
0.113 (1.00) |
7.54e-08 (3.05e-05) |
6.97e-24 (3.36e-21) |
0.169 (1.00) |
0.144 (1.00) |
Amp Peak 13(4p16 3) | 0 (0%) | 412 |
0.955 (1.00) |
3.31e-07 (0.00013) |
1.57e-13 (6.9e-11) |
0.596 (1.00) |
0.594 (1.00) |
Amp Peak 15(5q35 3) | 0 (0%) | 412 |
0.107 (1.00) |
0.000336 (0.115) |
8.19e-09 (3.41e-06) |
0.287 (1.00) |
0.711 (1.00) |
Amp Peak 16(6p24 2) | 0 (0%) | 366 |
0.878 (1.00) |
2.81e-07 (0.00011) |
2.75e-19 (1.3e-16) |
0.241 (1.00) |
0.82 (1.00) |
Amp Peak 19(8p11 21) | 0 (0%) | 319 |
1.06e-05 (0.00396) |
0.311 (1.00) |
1.04e-07 (4.14e-05) |
0.0322 (1.00) |
0.00362 (1.00) |
Amp Peak 21(8q24 21) | 0 (0%) | 277 |
0.00574 (1.00) |
0.208 (1.00) |
1.64e-14 (7.3e-12) |
0.0113 (1.00) |
0.000505 (0.17) |
Amp Peak 23(9q34 3) | 0 (0%) | 423 |
0.0768 (1.00) |
0.000631 (0.211) |
4.84e-07 (0.000189) |
0.689 (1.00) |
0.296 (1.00) |
Amp Peak 25(11p11 2) | 0 (0%) | 414 |
0.0367 (1.00) |
5.68e-05 (0.0204) |
3.48e-09 (1.45e-06) |
0.857 (1.00) |
0.435 (1.00) |
Amp Peak 30(13q34) | 0 (0%) | 409 |
0.844 (1.00) |
7.84e-07 (0.000303) |
2.62e-13 (1.15e-10) |
1 (1.00) |
0.13 (1.00) |
Amp Peak 31(14q24 3) | 0 (0%) | 406 |
0.543 (1.00) |
2.48e-05 (0.00905) |
8.06e-11 (3.45e-08) |
0.184 (1.00) |
0.738 (1.00) |
Amp Peak 32(14q32 33) | 0 (0%) | 395 |
0.174 (1.00) |
0.000223 (0.0771) |
7.04e-10 (2.97e-07) |
0.125 (1.00) |
0.142 (1.00) |
Amp Peak 33(16p11 2) | 0 (0%) | 404 |
0.0528 (1.00) |
0.000161 (0.0559) |
5.4e-15 (2.42e-12) |
0.871 (1.00) |
0.0359 (1.00) |
Amp Peak 35(17q12) | 0 (0%) | 397 |
0.0629 (1.00) |
2.18e-05 (0.00798) |
2.58e-18 (1.2e-15) |
0.757 (1.00) |
0.0855 (1.00) |
Amp Peak 36(17q25 1) | 0 (0%) | 376 |
0.0618 (1.00) |
2.1e-05 (0.00771) |
3.81e-16 (1.74e-13) |
0.892 (1.00) |
0.226 (1.00) |
Amp Peak 37(18p11 31) | 0 (0%) | 383 |
0.543 (1.00) |
0.000151 (0.0525) |
5.34e-20 (2.52e-17) |
0.0647 (1.00) |
0.00774 (1.00) |
Amp Peak 39(19p13 2) | 0 (0%) | 381 |
0.541 (1.00) |
1.42e-11 (6.14e-09) |
2.97e-19 (1.4e-16) |
0.262 (1.00) |
0.738 (1.00) |
Amp Peak 40(19p13 11) | 0 (0%) | 381 |
0.478 (1.00) |
1.13e-10 (4.83e-08) |
6.95e-22 (3.3e-19) |
0.0699 (1.00) |
0.294 (1.00) |
Amp Peak 41(19q12) | 0 (0%) | 370 |
0.0024 (0.752) |
1.98e-10 (8.42e-08) |
5.57e-36 (2.72e-33) |
0.692 (1.00) |
0.234 (1.00) |
Amp Peak 42(20p13) | 0 (0%) | 363 |
0.226 (1.00) |
1.07e-05 (0.00398) |
2.65e-13 (1.16e-10) |
0.248 (1.00) |
0.204 (1.00) |
Amp Peak 43(20q11 21) | 0 (0%) | 342 |
0.0355 (1.00) |
2.19e-07 (8.64e-05) |
5.4e-26 (2.62e-23) |
0.057 (1.00) |
0.0623 (1.00) |
Amp Peak 44(20q13 12) | 0 (0%) | 336 |
0.299 (1.00) |
3.14e-08 (1.28e-05) |
2.28e-23 (1.1e-20) |
0.0135 (1.00) |
0.0344 (1.00) |
Amp Peak 45(20q13 33) | 0 (0%) | 338 |
0.327 (1.00) |
1.19e-07 (4.73e-05) |
4.59e-19 (2.14e-16) |
0.00447 (1.00) |
0.0257 (1.00) |
Amp Peak 46(22q12 2) | 0 (0%) | 408 |
0.62 (1.00) |
0.00159 (0.508) |
2.87e-18 (1.33e-15) |
0.306 (1.00) |
0.00034 (0.116) |
Del Peak 1(1p36 21) | 0 (0%) | 399 |
0.546 (1.00) |
6.43e-05 (0.0228) |
1.36e-08 (5.62e-06) |
0.636 (1.00) |
0.346 (1.00) |
Del Peak 2(1p36 11) | 0 (0%) | 391 |
0.412 (1.00) |
1.2e-05 (0.00445) |
3.02e-13 (1.31e-10) |
0.766 (1.00) |
0.0111 (1.00) |
Del Peak 5(2q22 1) | 0 (0%) | 416 |
5.01e-08 (2.03e-05) |
0.00689 (1.00) |
5.29e-07 (0.000205) |
0.0245 (1.00) |
0.00345 (1.00) |
Del Peak 7(3p14 2) | 0 (0%) | 395 |
0.869 (1.00) |
2.02e-05 (0.00742) |
2.76e-15 (1.24e-12) |
0.359 (1.00) |
0.519 (1.00) |
Del Peak 9(4p16 3) | 0 (0%) | 384 |
0.108 (1.00) |
9.03e-05 (0.0318) |
7.73e-15 (3.45e-12) |
0.322 (1.00) |
0.618 (1.00) |
Del Peak 10(4p15 31) | 0 (0%) | 383 |
0.13 (1.00) |
3.68e-05 (0.0133) |
5.23e-14 (2.32e-11) |
0.118 (1.00) |
0.232 (1.00) |
Del Peak 11(4q22 1) | 0 (0%) | 375 |
0.00625 (1.00) |
1.31e-05 (0.00487) |
2.36e-23 (1.13e-20) |
0.279 (1.00) |
0.0316 (1.00) |
Del Peak 12(4q34 3) | 0 (0%) | 357 |
0.0255 (1.00) |
3.81e-06 (0.00145) |
2.5e-25 (1.21e-22) |
0.383 (1.00) |
0.0968 (1.00) |
Del Peak 13(5q11 2) | 0 (0%) | 373 |
0.108 (1.00) |
4.87e-05 (0.0176) |
2.84e-22 (1.35e-19) |
0.687 (1.00) |
0.342 (1.00) |
Del Peak 15(7p22 3) | 0 (0%) | 395 |
0.014 (1.00) |
5.25e-05 (0.0189) |
2.22e-13 (9.73e-11) |
0.541 (1.00) |
0.0854 (1.00) |
Del Peak 16(7q11 22) | 0 (0%) | 422 |
0.564 (1.00) |
9.89e-06 (0.00371) |
9.39e-08 (3.78e-05) |
0.689 (1.00) |
0.454 (1.00) |
Del Peak 17(7q31 1) | 0 (0%) | 414 |
0.716 (1.00) |
2.62e-06 (0.000999) |
5.76e-16 (2.63e-13) |
0.717 (1.00) |
0.24 (1.00) |
Del Peak 18(7q36 3) | 0 (0%) | 404 |
0.622 (1.00) |
3.12e-08 (1.27e-05) |
3.54e-16 (1.62e-13) |
1 (1.00) |
0.139 (1.00) |
Del Peak 21(9q34 11) | 0 (0%) | 350 |
0.223 (1.00) |
1.12e-09 (4.7e-07) |
1.16e-17 (5.37e-15) |
0.394 (1.00) |
0.311 (1.00) |
Del Peak 23(11p15 5) | 0 (0%) | 374 |
0.00894 (1.00) |
2.53e-08 (1.04e-05) |
2.95e-21 (1.4e-18) |
0.0801 (1.00) |
0.0248 (1.00) |
Del Peak 24(11q14 1) | 0 (0%) | 400 |
0.0579 (1.00) |
1.32e-05 (0.00489) |
2.57e-15 (1.16e-12) |
0.427 (1.00) |
0.534 (1.00) |
Del Peak 25(11q25) | 0 (0%) | 382 |
0.00389 (1.00) |
8.1e-05 (0.0286) |
9.51e-16 (4.31e-13) |
0.0236 (1.00) |
0.261 (1.00) |
Del Peak 27(12q24 33) | 0 (0%) | 407 |
0.109 (1.00) |
5.99e-05 (0.0213) |
1.3e-13 (5.72e-11) |
0.128 (1.00) |
0.015 (1.00) |
Del Peak 29(13q14 2) | 0 (0%) | 380 |
0.0496 (1.00) |
0.000338 (0.116) |
2.96e-05 (0.0108) |
0.125 (1.00) |
0.214 (1.00) |
Del Peak 30(14q13 1) | 0 (0%) | 398 |
0.00228 (0.719) |
0.00062 (0.208) |
1.43e-11 (6.15e-09) |
0.755 (1.00) |
0.881 (1.00) |
Del Peak 31(15q15 1) | 0 (0%) | 346 |
0.0241 (1.00) |
1.36e-08 (5.62e-06) |
4.8e-22 (2.29e-19) |
0.0695 (1.00) |
0.0275 (1.00) |
Del Peak 32(15q23) | 0 (0%) | 365 |
0.0449 (1.00) |
5.94e-06 (0.00223) |
6.56e-23 (3.14e-20) |
0.196 (1.00) |
0.439 (1.00) |
Del Peak 33(16p13 3) | 0 (0%) | 388 |
0.0262 (1.00) |
2.08e-08 (8.53e-06) |
2.15e-17 (9.92e-15) |
0.56 (1.00) |
0.0176 (1.00) |
Del Peak 34(16q21) | 0 (0%) | 332 |
0.033 (1.00) |
1.42e-09 (5.96e-07) |
2.86e-23 (1.37e-20) |
0.296 (1.00) |
0.129 (1.00) |
Del Peak 35(16q23 1) | 0 (0%) | 322 |
0.0407 (1.00) |
1.11e-08 (4.59e-06) |
6.27e-27 (3.05e-24) |
0.428 (1.00) |
0.00536 (1.00) |
Del Peak 36(17p13 3) | 0 (0%) | 364 |
0.0883 (1.00) |
5.79e-05 (0.0207) |
3.99e-19 (1.87e-16) |
0.302 (1.00) |
0.151 (1.00) |
Del Peak 37(17p12) | 0 (0%) | 352 |
0.0567 (1.00) |
1.18e-07 (4.71e-05) |
3.95e-26 (1.92e-23) |
0.463 (1.00) |
0.666 (1.00) |
Del Peak 38(17p11 2) | 0 (0%) | 361 |
0.0323 (1.00) |
1.35e-06 (0.000523) |
2.11e-19 (9.94e-17) |
0.445 (1.00) |
0.744 (1.00) |
Del Peak 39(17q11 2) | 0 (0%) | 373 |
0.497 (1.00) |
5.19e-06 (0.00196) |
3.24e-11 (1.39e-08) |
0.139 (1.00) |
0.181 (1.00) |
Del Peak 40(17q21 2) | 0 (0%) | 367 |
0.11 (1.00) |
4.94e-06 (0.00187) |
1.6e-15 (7.24e-13) |
0.152 (1.00) |
0.0717 (1.00) |
Del Peak 42(19p13 3) | 0 (0%) | 332 |
0.00973 (1.00) |
5.7e-12 (2.47e-09) |
1.55e-49 (7.58e-47) |
0.296 (1.00) |
0.00413 (1.00) |
Del Peak 46(22q11 1) | 0 (0%) | 385 |
0.319 (1.00) |
6.01e-05 (0.0213) |
2.23e-06 (0.000855) |
0.0152 (1.00) |
0.579 (1.00) |
Del Peak 48(22q13 31) | 0 (0%) | 350 |
0.0103 (1.00) |
1.13e-08 (4.67e-06) |
5.4e-19 (2.52e-16) |
0.179 (1.00) |
0.782 (1.00) |
Del Peak 49(22q13 32) | 0 (0%) | 345 |
0.0073 (1.00) |
1.62e-07 (6.42e-05) |
3.49e-19 (1.64e-16) |
0.0541 (1.00) |
0.541 (1.00) |
Del Peak 50(Xp21 1) | 0 (0%) | 388 |
0.00351 (1.00) |
5.69e-05 (0.0204) |
2.97e-14 (1.32e-11) |
0.381 (1.00) |
0.102 (1.00) |
Amp Peak 3(1p22 3) | 0 (0%) | 378 |
0.603 (1.00) |
0.000345 (0.117) |
0.00174 (0.551) |
1 (1.00) |
0.466 (1.00) |
Amp Peak 7(2p23 2) | 0 (0%) | 355 |
0.0076 (1.00) |
0.00151 (0.482) |
1.1e-13 (4.87e-11) |
0.0461 (1.00) |
0.83 (1.00) |
Amp Peak 10(3p14 1) | 0 (0%) | 404 |
0.00572 (1.00) |
0.00906 (1.00) |
0.000132 (0.046) |
0.0317 (1.00) |
0.377 (1.00) |
Amp Peak 14(5p15 33) | 0 (0%) | 387 |
0.0584 (1.00) |
0.00452 (1.00) |
2.21e-16 (1.01e-13) |
0.47 (1.00) |
0.0905 (1.00) |
Amp Peak 17(6q25 1) | 0 (0%) | 388 |
0.817 (1.00) |
0.00529 (1.00) |
1.79e-05 (0.0066) |
0.771 (1.00) |
0.261 (1.00) |
Amp Peak 20(8q24 21) | 0 (0%) | 286 |
0.00109 (0.355) |
0.531 (1.00) |
6.02e-13 (2.62e-10) |
0.0255 (1.00) |
0.0329 (1.00) |
Amp Peak 22(9p24 2) | 0 (0%) | 405 |
0.812 (1.00) |
0.00482 (1.00) |
1.28e-07 (5.07e-05) |
0.32 (1.00) |
0.445 (1.00) |
Amp Peak 26(11q13 2) | 0 (0%) | 396 |
0.0893 (1.00) |
0.000754 (0.25) |
1.01e-07 (4.04e-05) |
0.76 (1.00) |
0.139 (1.00) |
Amp Peak 27(12p12 1) | 0 (0%) | 384 |
0.859 (1.00) |
0.299 (1.00) |
4.45e-08 (1.81e-05) |
0.672 (1.00) |
0.295 (1.00) |
Amp Peak 28(12q13 11) | 0 (0%) | 385 |
0.712 (1.00) |
0.853 (1.00) |
9.62e-08 (3.86e-05) |
0.252 (1.00) |
0.256 (1.00) |
Amp Peak 29(12q13 2) | 0 (0%) | 378 |
0.995 (1.00) |
0.0485 (1.00) |
5.01e-07 (0.000195) |
0.0975 (1.00) |
0.0586 (1.00) |
Amp Peak 38(18q11 2) | 0 (0%) | 398 |
0.185 (1.00) |
0.0032 (1) |
3.11e-15 (1.4e-12) |
0.532 (1.00) |
0.044 (1.00) |
Amp Peak 48(Xq28) | 0 (0%) | 379 |
0.00851 (1.00) |
0.0604 (1.00) |
0.000354 (0.12) |
1 (1.00) |
0.243 (1.00) |
Del Peak 8(3q13 31) | 0 (0%) | 432 |
0.76 (1.00) |
0.00168 (0.535) |
3.38e-06 (0.00128) |
0.633 (1.00) |
0.928 (1.00) |
Del Peak 14(6q26) | 0 (0%) | 417 |
0.36 (1.00) |
0.00589 (1.00) |
2.21e-09 (9.26e-07) |
1 (1.00) |
0.777 (1.00) |
Del Peak 19(8p23 2) | 0 (0%) | 367 |
0.319 (1.00) |
0.00094 (0.309) |
6.04e-27 (2.95e-24) |
0.516 (1.00) |
0.013 (1.00) |
Del Peak 20(9p23) | 0 (0%) | 401 |
0.313 (1.00) |
0.000868 (0.287) |
3.04e-11 (1.31e-08) |
0.266 (1.00) |
0.244 (1.00) |
Del Peak 22(10q23 31) | 0 (0%) | 398 |
0.101 (1.00) |
0.00351 (1.00) |
2.6e-06 (0.000992) |
0.0426 (1.00) |
0.0901 (1.00) |
Del Peak 26(12q23 1) | 0 (0%) | 420 |
0.0516 (1.00) |
0.00608 (1.00) |
2.44e-10 (1.04e-07) |
0.558 (1.00) |
0.0205 (1.00) |
Del Peak 28(13q11) | 0 (0%) | 385 |
0.0184 (1.00) |
0.00108 (0.355) |
4.54e-10 (1.92e-07) |
0.252 (1.00) |
0.0622 (1.00) |
Del Peak 41(18q23) | 0 (0%) | 379 |
0.0102 (1.00) |
0.00109 (0.356) |
9.72e-15 (4.33e-12) |
0.00527 (1.00) |
0.00794 (1.00) |
Del Peak 43(19p12) | 0 (0%) | 414 |
0.0627 (1.00) |
0.0568 (1.00) |
4.24e-08 (1.72e-05) |
0.205 (1.00) |
0.404 (1.00) |
Del Peak 44(19q13 43) | 0 (0%) | 403 |
0.00131 (0.422) |
0.00117 (0.376) |
6.17e-16 (2.8e-13) |
0.871 (1.00) |
0.0278 (1.00) |
Del Peak 45(20p12 1) | 0 (0%) | 428 |
0.0641 (1.00) |
0.0686 (1.00) |
0.000708 (0.236) |
0.829 (1.00) |
0.159 (1.00) |
Del Peak 47(22q12 1) | 0 (0%) | 381 |
0.123 (1.00) |
0.00113 (0.368) |
4.35e-07 (0.00017) |
0.0699 (1.00) |
0.528 (1.00) |
Amp Peak 6(1q42 3) | 0 (0%) | 266 |
0.307 (1.00) |
0.00125 (0.401) |
0.114 (1.00) |
0.676 (1.00) |
0.346 (1.00) |
Amp Peak 18(7q22 1) | 0 (0%) | 382 |
0.00082 (0.272) |
0.0546 (1.00) |
0.0029 (0.908) |
0.16 (1.00) |
0.481 (1.00) |
Amp Peak 24(10q22 2) | 0 (0%) | 331 |
0.205 (1.00) |
0.439 (1.00) |
0.0428 (1.00) |
0.644 (1.00) |
0.389 (1.00) |
Amp Peak 47(Xp11 23) | 0 (0%) | 379 |
0.46 (1.00) |
0.156 (1.00) |
0.00902 (1.00) |
0.0264 (1.00) |
0.366 (1.00) |
Del Peak 3(1q43) | 0 (0%) | 446 |
0.0199 (1.00) |
0.0475 (1.00) |
0.106 (1.00) |
0.112 (1.00) |
0.0338 (1.00) |
Del Peak 4(2p25 3) | 0 (0%) | 432 |
0.0465 (1.00) |
0.131 (1.00) |
0.00641 (1.00) |
0.148 (1.00) |
0.201 (1.00) |
Del Peak 6(2q37 3) | 0 (0%) | 411 |
0.383 (1.00) |
0.00115 (0.373) |
0.0018 (0.567) |
0.222 (1.00) |
0.038 (1.00) |
P value = 0.000141 (t-test), Q value = 0.049
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 1(1P35.2) CNV | 44 | 68.9 (8.7) |
AMP PEAK 1(1P35.2) WILD-TYPE | 409 | 63.1 (11.4) |
P value = 2.03e-12 (Fisher's exact test), Q value = 8.8e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 1(1P35.2) CNV | 13 | 4 | 27 |
AMP PEAK 1(1P35.2) WILD-TYPE | 338 | 14 | 58 |
P value = 3.48e-05 (t-test), Q value = 0.013
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 2(1P34.2) CNV | 55 | 69.1 (9.6) |
AMP PEAK 2(1P34.2) WILD-TYPE | 398 | 62.9 (11.3) |
P value = 3.96e-17 (Fisher's exact test), Q value = 1.8e-14
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 2(1P34.2) CNV | 15 | 6 | 34 |
AMP PEAK 2(1P34.2) WILD-TYPE | 336 | 12 | 51 |
P value = 0.000345 (t-test), Q value = 0.12
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 3(1P22.3) CNV | 76 | 67.6 (10.0) |
AMP PEAK 3(1P22.3) WILD-TYPE | 377 | 62.8 (11.3) |
P value = 1.99e-06 (t-test), Q value = 0.00077
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 4(1Q21.3) CNV | 201 | 66.4 (10.5) |
AMP PEAK 4(1Q21.3) WILD-TYPE | 252 | 61.4 (11.4) |
P value = 0.000332 (Fisher's exact test), Q value = 0.11
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 4(1Q21.3) CNV | 139 | 8 | 54 |
AMP PEAK 4(1Q21.3) WILD-TYPE | 212 | 10 | 31 |
P value = 9.36e-08 (t-test), Q value = 3.8e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 5(1Q22) CNV | 213 | 66.6 (10.4) |
AMP PEAK 5(1Q22) WILD-TYPE | 240 | 61.0 (11.3) |
P value = 1.38e-06 (Fisher's exact test), Q value = 0.00053
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 5(1Q22) CNV | 144 | 8 | 61 |
AMP PEAK 5(1Q22) WILD-TYPE | 207 | 10 | 24 |
P value = 1.1e-13 (Fisher's exact test), Q value = 4.9e-11
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 7(2P23.2) CNV | 47 | 7 | 45 |
AMP PEAK 7(2P23.2) WILD-TYPE | 304 | 11 | 40 |
P value = 0.000122 (t-test), Q value = 0.043
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 8(2Q13) CNV | 91 | 67.2 (9.0) |
AMP PEAK 8(2Q13) WILD-TYPE | 362 | 62.7 (11.6) |
P value = 6.05e-16 (Fisher's exact test), Q value = 2.8e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 8(2Q13) CNV | 41 | 4 | 47 |
AMP PEAK 8(2Q13) WILD-TYPE | 310 | 14 | 38 |
P value = 0.000132 (t-test), Q value = 0.046
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 9(3P25.1) CNV | 63 | 68.7 (10.8) |
AMP PEAK 9(3P25.1) WILD-TYPE | 390 | 62.8 (11.1) |
P value = 1.69e-09 (Fisher's exact test), Q value = 7.1e-07
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 9(3P25.1) CNV | 30 | 1 | 32 |
AMP PEAK 9(3P25.1) WILD-TYPE | 321 | 17 | 53 |
P value = 0.000132 (Fisher's exact test), Q value = 0.046
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 10(3P14.1) CNV | 27 | 2 | 21 |
AMP PEAK 10(3P14.1) WILD-TYPE | 324 | 16 | 64 |
P value = 4.28e-10 (t-test), Q value = 1.8e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 11(3Q26.2) CNV | 134 | 68.4 (9.5) |
AMP PEAK 11(3Q26.2) WILD-TYPE | 319 | 61.7 (11.4) |
P value = 2.49e-24 (Fisher's exact test), Q value = 1.2e-21
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 11(3Q26.2) CNV | 62 | 7 | 65 |
AMP PEAK 11(3Q26.2) WILD-TYPE | 289 | 11 | 20 |
P value = 7.54e-08 (t-test), Q value = 3e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 12(3Q26.2) CNV | 126 | 67.9 (9.6) |
AMP PEAK 12(3Q26.2) WILD-TYPE | 327 | 62.0 (11.4) |
P value = 6.97e-24 (Fisher's exact test), Q value = 3.4e-21
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 12(3Q26.2) CNV | 57 | 6 | 63 |
AMP PEAK 12(3Q26.2) WILD-TYPE | 294 | 12 | 22 |
P value = 3.31e-07 (t-test), Q value = 0.00013
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 13(4P16.3) CNV | 42 | 70.9 (8.2) |
AMP PEAK 13(4P16.3) WILD-TYPE | 411 | 62.9 (11.3) |
P value = 1.57e-13 (Fisher's exact test), Q value = 6.9e-11
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 13(4P16.3) CNV | 12 | 1 | 29 |
AMP PEAK 13(4P16.3) WILD-TYPE | 339 | 17 | 56 |
P value = 2.21e-16 (Fisher's exact test), Q value = 1e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 14(5P15.33) CNV | 24 | 3 | 40 |
AMP PEAK 14(5P15.33) WILD-TYPE | 327 | 15 | 45 |
P value = 0.000336 (t-test), Q value = 0.12
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 15(5Q35.3) CNV | 42 | 69.7 (10.7) |
AMP PEAK 15(5Q35.3) WILD-TYPE | 411 | 63.0 (11.1) |
P value = 8.19e-09 (Fisher's exact test), Q value = 3.4e-06
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 15(5Q35.3) CNV | 16 | 2 | 24 |
AMP PEAK 15(5Q35.3) WILD-TYPE | 335 | 16 | 61 |
P value = 2.81e-07 (t-test), Q value = 0.00011
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 16(6P24.2) CNV | 88 | 68.9 (9.9) |
AMP PEAK 16(6P24.2) WILD-TYPE | 365 | 62.4 (11.2) |
P value = 2.75e-19 (Fisher's exact test), Q value = 1.3e-16
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 16(6P24.2) CNV | 35 | 4 | 49 |
AMP PEAK 16(6P24.2) WILD-TYPE | 316 | 14 | 36 |
P value = 1.79e-05 (Fisher's exact test), Q value = 0.0066
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 17(6Q25.1) CNV | 37 | 2 | 27 |
AMP PEAK 17(6Q25.1) WILD-TYPE | 314 | 16 | 58 |
P value = 1.06e-05 (logrank test), Q value = 0.004
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 450 | 42 | 0.0 - 187.1 (15.5) |
AMP PEAK 19(8P11.21) CNV | 134 | 23 | 0.0 - 113.2 (11.4) |
AMP PEAK 19(8P11.21) WILD-TYPE | 316 | 19 | 0.0 - 187.1 (16.8) |
P value = 1.04e-07 (Fisher's exact test), Q value = 4.1e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 19(8P11.21) CNV | 82 | 6 | 47 |
AMP PEAK 19(8P11.21) WILD-TYPE | 269 | 12 | 38 |
P value = 6.02e-13 (Fisher's exact test), Q value = 2.6e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 20(8Q24.21) CNV | 99 | 8 | 61 |
AMP PEAK 20(8Q24.21) WILD-TYPE | 252 | 10 | 24 |
P value = 1.64e-14 (Fisher's exact test), Q value = 7.3e-12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 21(8Q24.21) CNV | 105 | 7 | 65 |
AMP PEAK 21(8Q24.21) WILD-TYPE | 246 | 11 | 20 |
P value = 0.000505 (Fisher's exact test), Q value = 0.17
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 311 | 24 | 15 | 25 |
AMP PEAK 21(8Q24.21) CNV | 119 | 5 | 13 | 10 |
AMP PEAK 21(8Q24.21) WILD-TYPE | 192 | 19 | 2 | 15 |
P value = 1.28e-07 (Fisher's exact test), Q value = 5.1e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 22(9P24.2) CNV | 22 | 2 | 25 |
AMP PEAK 22(9P24.2) WILD-TYPE | 329 | 16 | 60 |
P value = 0.000631 (t-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 23(9Q34.3) CNV | 31 | 69.0 (8.0) |
AMP PEAK 23(9Q34.3) WILD-TYPE | 422 | 63.2 (11.4) |
P value = 4.84e-07 (Fisher's exact test), Q value = 0.00019
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 23(9Q34.3) CNV | 11 | 4 | 16 |
AMP PEAK 23(9Q34.3) WILD-TYPE | 340 | 14 | 69 |
P value = 5.68e-05 (t-test), Q value = 0.02
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 25(11P11.2) CNV | 40 | 69.9 (9.3) |
AMP PEAK 25(11P11.2) WILD-TYPE | 413 | 63.0 (11.2) |
P value = 3.48e-09 (Fisher's exact test), Q value = 1.4e-06
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 25(11P11.2) CNV | 14 | 3 | 23 |
AMP PEAK 25(11P11.2) WILD-TYPE | 337 | 15 | 62 |
P value = 1.01e-07 (Fisher's exact test), Q value = 4e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 26(11Q13.2) CNV | 28 | 2 | 28 |
AMP PEAK 26(11Q13.2) WILD-TYPE | 323 | 16 | 57 |
P value = 4.45e-08 (Fisher's exact test), Q value = 1.8e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 27(12P12.1) CNV | 36 | 2 | 32 |
AMP PEAK 27(12P12.1) WILD-TYPE | 315 | 16 | 53 |
P value = 9.62e-08 (Fisher's exact test), Q value = 3.9e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 28(12Q13.11) CNV | 35 | 3 | 31 |
AMP PEAK 28(12Q13.11) WILD-TYPE | 316 | 15 | 54 |
P value = 5.01e-07 (Fisher's exact test), Q value = 0.00019
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 29(12Q13.2) CNV | 41 | 3 | 32 |
AMP PEAK 29(12Q13.2) WILD-TYPE | 310 | 15 | 53 |
P value = 7.84e-07 (t-test), Q value = 3e-04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 30(13Q34) CNV | 45 | 69.7 (7.4) |
AMP PEAK 30(13Q34) WILD-TYPE | 408 | 63.0 (11.4) |
P value = 2.62e-13 (Fisher's exact test), Q value = 1.1e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 30(13Q34) CNV | 13 | 3 | 29 |
AMP PEAK 30(13Q34) WILD-TYPE | 338 | 15 | 56 |
P value = 2.48e-05 (t-test), Q value = 0.0091
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 31(14Q24.3) CNV | 48 | 69.0 (8.4) |
AMP PEAK 31(14Q24.3) WILD-TYPE | 405 | 63.0 (11.4) |
P value = 8.06e-11 (Fisher's exact test), Q value = 3.5e-08
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 31(14Q24.3) CNV | 17 | 4 | 27 |
AMP PEAK 31(14Q24.3) WILD-TYPE | 334 | 14 | 58 |
P value = 0.000223 (t-test), Q value = 0.077
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 32(14Q32.33) CNV | 59 | 68.2 (9.5) |
AMP PEAK 32(14Q32.33) WILD-TYPE | 394 | 63.0 (11.3) |
P value = 7.04e-10 (Fisher's exact test), Q value = 3e-07
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 32(14Q32.33) CNV | 25 | 4 | 30 |
AMP PEAK 32(14Q32.33) WILD-TYPE | 326 | 14 | 55 |
P value = 0.000161 (t-test), Q value = 0.056
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 33(16P11.2) CNV | 50 | 68.4 (8.6) |
AMP PEAK 33(16P11.2) WILD-TYPE | 403 | 63.0 (11.4) |
P value = 5.4e-15 (Fisher's exact test), Q value = 2.4e-12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 33(16P11.2) CNV | 15 | 2 | 33 |
AMP PEAK 33(16P11.2) WILD-TYPE | 336 | 16 | 52 |
P value = 0.000348 (t-test), Q value = 0.12
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 34(17Q11.2) CNV | 54 | 67.9 (8.5) |
AMP PEAK 34(17Q11.2) WILD-TYPE | 399 | 63.1 (11.5) |
P value = 1.35e-16 (Fisher's exact test), Q value = 6.2e-14
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 34(17Q11.2) CNV | 15 | 5 | 34 |
AMP PEAK 34(17Q11.2) WILD-TYPE | 336 | 13 | 51 |
P value = 0.000427 (Fisher's exact test), Q value = 0.14
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 311 | 24 | 15 | 25 |
AMP PEAK 34(17Q11.2) CNV | 29 | 7 | 6 | 4 |
AMP PEAK 34(17Q11.2) WILD-TYPE | 282 | 17 | 9 | 21 |
P value = 2.18e-05 (t-test), Q value = 0.008
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 35(17Q12) CNV | 57 | 69.1 (9.4) |
AMP PEAK 35(17Q12) WILD-TYPE | 396 | 62.9 (11.3) |
P value = 2.58e-18 (Fisher's exact test), Q value = 1.2e-15
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 35(17Q12) CNV | 16 | 3 | 38 |
AMP PEAK 35(17Q12) WILD-TYPE | 335 | 15 | 47 |
P value = 2.1e-05 (t-test), Q value = 0.0077
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 36(17Q25.1) CNV | 78 | 68.0 (9.1) |
AMP PEAK 36(17Q25.1) WILD-TYPE | 375 | 62.7 (11.5) |
P value = 3.81e-16 (Fisher's exact test), Q value = 1.7e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 36(17Q25.1) CNV | 30 | 8 | 40 |
AMP PEAK 36(17Q25.1) WILD-TYPE | 321 | 10 | 45 |
P value = 0.000151 (t-test), Q value = 0.053
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 37(18P11.31) CNV | 71 | 67.7 (9.2) |
AMP PEAK 37(18P11.31) WILD-TYPE | 382 | 62.9 (11.4) |
P value = 5.34e-20 (Fisher's exact test), Q value = 2.5e-17
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 37(18P11.31) CNV | 23 | 4 | 44 |
AMP PEAK 37(18P11.31) WILD-TYPE | 328 | 14 | 41 |
P value = 3.11e-15 (Fisher's exact test), Q value = 1.4e-12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 38(18Q11.2) CNV | 18 | 3 | 35 |
AMP PEAK 38(18Q11.2) WILD-TYPE | 333 | 15 | 50 |
P value = 1.42e-11 (t-test), Q value = 6.1e-09
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 39(19P13.2) CNV | 73 | 70.7 (8.4) |
AMP PEAK 39(19P13.2) WILD-TYPE | 380 | 62.3 (11.2) |
P value = 2.97e-19 (Fisher's exact test), Q value = 1.4e-16
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 39(19P13.2) CNV | 24 | 7 | 42 |
AMP PEAK 39(19P13.2) WILD-TYPE | 327 | 11 | 43 |
P value = 1.13e-10 (t-test), Q value = 4.8e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 40(19P13.11) CNV | 73 | 70.7 (9.0) |
AMP PEAK 40(19P13.11) WILD-TYPE | 380 | 62.3 (11.1) |
P value = 6.95e-22 (Fisher's exact test), Q value = 3.3e-19
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 40(19P13.11) CNV | 22 | 6 | 45 |
AMP PEAK 40(19P13.11) WILD-TYPE | 329 | 12 | 40 |
P value = 1.98e-10 (t-test), Q value = 8.4e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 41(19Q12) CNV | 84 | 69.5 (8.1) |
AMP PEAK 41(19Q12) WILD-TYPE | 369 | 62.3 (11.4) |
P value = 5.57e-36 (Fisher's exact test), Q value = 2.7e-33
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 41(19Q12) CNV | 18 | 9 | 57 |
AMP PEAK 41(19Q12) WILD-TYPE | 333 | 9 | 28 |
P value = 1.07e-05 (t-test), Q value = 0.004
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 42(20P13) CNV | 91 | 68.4 (11.1) |
AMP PEAK 42(20P13) WILD-TYPE | 362 | 62.4 (11.0) |
P value = 2.65e-13 (Fisher's exact test), Q value = 1.2e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 42(20P13) CNV | 43 | 4 | 44 |
AMP PEAK 42(20P13) WILD-TYPE | 308 | 14 | 41 |
P value = 2.19e-07 (t-test), Q value = 8.6e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 43(20Q11.21) CNV | 112 | 68.2 (9.9) |
AMP PEAK 43(20Q11.21) WILD-TYPE | 341 | 62.2 (11.3) |
P value = 5.4e-26 (Fisher's exact test), Q value = 2.6e-23
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 43(20Q11.21) CNV | 45 | 6 | 61 |
AMP PEAK 43(20Q11.21) WILD-TYPE | 306 | 12 | 24 |
P value = 3.14e-08 (t-test), Q value = 1.3e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 44(20Q13.12) CNV | 118 | 68.4 (10.3) |
AMP PEAK 44(20Q13.12) WILD-TYPE | 335 | 62.0 (11.1) |
P value = 2.28e-23 (Fisher's exact test), Q value = 1.1e-20
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 44(20Q13.12) CNV | 51 | 7 | 60 |
AMP PEAK 44(20Q13.12) WILD-TYPE | 300 | 11 | 25 |
P value = 1.19e-07 (t-test), Q value = 4.7e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
AMP PEAK 45(20Q13.33) CNV | 116 | 68.3 (10.4) |
AMP PEAK 45(20Q13.33) WILD-TYPE | 337 | 62.0 (11.1) |
P value = 4.59e-19 (Fisher's exact test), Q value = 2.1e-16
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 45(20Q13.33) CNV | 54 | 6 | 56 |
AMP PEAK 45(20Q13.33) WILD-TYPE | 297 | 12 | 29 |
P value = 2.87e-18 (Fisher's exact test), Q value = 1.3e-15
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 46(22Q12.2) CNV | 10 | 2 | 34 |
AMP PEAK 46(22Q12.2) WILD-TYPE | 341 | 16 | 51 |
P value = 0.00034 (Fisher's exact test), Q value = 0.12
nPatients | R0 | R1 | R2 | RX |
---|---|---|---|---|
ALL | 311 | 24 | 15 | 25 |
AMP PEAK 46(22Q12.2) CNV | 24 | 2 | 7 | 4 |
AMP PEAK 46(22Q12.2) WILD-TYPE | 287 | 22 | 8 | 21 |
P value = 0.000354 (Fisher's exact test), Q value = 0.12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
AMP PEAK 48(XQ28) CNV | 46 | 2 | 27 |
AMP PEAK 48(XQ28) WILD-TYPE | 305 | 16 | 58 |
P value = 6.43e-05 (t-test), Q value = 0.023
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 1(1P36.21) CNV | 55 | 69.3 (10.4) |
DEL PEAK 1(1P36.21) WILD-TYPE | 398 | 62.9 (11.2) |
P value = 1.36e-08 (Fisher's exact test), Q value = 5.6e-06
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 1(1P36.21) CNV | 24 | 4 | 27 |
DEL PEAK 1(1P36.21) WILD-TYPE | 327 | 14 | 58 |
P value = 1.2e-05 (t-test), Q value = 0.0045
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 2(1P36.11) CNV | 63 | 69.0 (9.7) |
DEL PEAK 2(1P36.11) WILD-TYPE | 390 | 62.8 (11.2) |
P value = 3.02e-13 (Fisher's exact test), Q value = 1.3e-10
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 2(1P36.11) CNV | 24 | 4 | 35 |
DEL PEAK 2(1P36.11) WILD-TYPE | 327 | 14 | 50 |
P value = 5.01e-08 (logrank test), Q value = 2e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 450 | 42 | 0.0 - 187.1 (15.5) |
DEL PEAK 5(2Q22.1) CNV | 38 | 11 | 0.1 - 113.2 (7.4) |
DEL PEAK 5(2Q22.1) WILD-TYPE | 412 | 31 | 0.0 - 187.1 (16.6) |
P value = 5.29e-07 (Fisher's exact test), Q value = 0.00021
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 5(2Q22.1) CNV | 16 | 1 | 21 |
DEL PEAK 5(2Q22.1) WILD-TYPE | 335 | 17 | 64 |
P value = 2.02e-05 (t-test), Q value = 0.0074
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 7(3P14.2) CNV | 59 | 68.0 (7.4) |
DEL PEAK 7(3P14.2) WILD-TYPE | 394 | 63.0 (11.6) |
P value = 2.76e-15 (Fisher's exact test), Q value = 1.2e-12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 7(3P14.2) CNV | 19 | 6 | 34 |
DEL PEAK 7(3P14.2) WILD-TYPE | 332 | 12 | 51 |
P value = 3.38e-06 (Fisher's exact test), Q value = 0.0013
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 8(3Q13.31) CNV | 7 | 1 | 14 |
DEL PEAK 8(3Q13.31) WILD-TYPE | 344 | 17 | 71 |
P value = 9.03e-05 (t-test), Q value = 0.032
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 9(4P16.3) CNV | 70 | 67.9 (9.3) |
DEL PEAK 9(4P16.3) WILD-TYPE | 383 | 62.9 (11.4) |
P value = 7.73e-15 (Fisher's exact test), Q value = 3.5e-12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 9(4P16.3) CNV | 27 | 4 | 39 |
DEL PEAK 9(4P16.3) WILD-TYPE | 324 | 14 | 46 |
P value = 3.68e-05 (t-test), Q value = 0.013
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 10(4P15.31) CNV | 71 | 68.2 (9.5) |
DEL PEAK 10(4P15.31) WILD-TYPE | 382 | 62.8 (11.3) |
P value = 5.23e-14 (Fisher's exact test), Q value = 2.3e-11
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 10(4P15.31) CNV | 29 | 3 | 39 |
DEL PEAK 10(4P15.31) WILD-TYPE | 322 | 15 | 46 |
P value = 1.31e-05 (t-test), Q value = 0.0049
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 11(4Q22.1) CNV | 79 | 68.1 (9.1) |
DEL PEAK 11(4Q22.1) WILD-TYPE | 374 | 62.7 (11.4) |
P value = 2.36e-23 (Fisher's exact test), Q value = 1.1e-20
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 11(4Q22.1) CNV | 25 | 5 | 49 |
DEL PEAK 11(4Q22.1) WILD-TYPE | 326 | 13 | 36 |
P value = 3.81e-06 (t-test), Q value = 0.0014
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 12(4Q34.3) CNV | 97 | 68.0 (9.9) |
DEL PEAK 12(4Q34.3) WILD-TYPE | 356 | 62.4 (11.3) |
P value = 2.5e-25 (Fisher's exact test), Q value = 1.2e-22
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 12(4Q34.3) CNV | 35 | 6 | 56 |
DEL PEAK 12(4Q34.3) WILD-TYPE | 316 | 12 | 29 |
P value = 4.87e-05 (t-test), Q value = 0.018
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 13(5Q11.2) CNV | 81 | 67.9 (9.8) |
DEL PEAK 13(5Q11.2) WILD-TYPE | 372 | 62.7 (11.3) |
P value = 2.84e-22 (Fisher's exact test), Q value = 1.4e-19
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 13(5Q11.2) CNV | 29 | 2 | 50 |
DEL PEAK 13(5Q11.2) WILD-TYPE | 322 | 16 | 35 |
P value = 2.21e-09 (Fisher's exact test), Q value = 9.3e-07
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 14(6Q26) CNV | 12 | 3 | 22 |
DEL PEAK 14(6Q26) WILD-TYPE | 339 | 15 | 63 |
P value = 5.25e-05 (t-test), Q value = 0.019
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 15(7P22.3) CNV | 58 | 68.7 (9.5) |
DEL PEAK 15(7P22.3) WILD-TYPE | 395 | 62.9 (11.3) |
P value = 2.22e-13 (Fisher's exact test), Q value = 9.7e-11
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 15(7P22.3) CNV | 21 | 5 | 33 |
DEL PEAK 15(7P22.3) WILD-TYPE | 330 | 13 | 52 |
P value = 9.89e-06 (t-test), Q value = 0.0037
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 16(7Q11.22) CNV | 32 | 71.2 (8.5) |
DEL PEAK 16(7Q11.22) WILD-TYPE | 421 | 63.1 (11.2) |
P value = 9.39e-08 (Fisher's exact test), Q value = 3.8e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 16(7Q11.22) CNV | 11 | 2 | 19 |
DEL PEAK 16(7Q11.22) WILD-TYPE | 340 | 16 | 66 |
P value = 2.62e-06 (t-test), Q value = 0.001
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 17(7Q31.1) CNV | 40 | 69.9 (7.5) |
DEL PEAK 17(7Q31.1) WILD-TYPE | 413 | 63.0 (11.4) |
P value = 5.76e-16 (Fisher's exact test), Q value = 2.6e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 17(7Q31.1) CNV | 8 | 3 | 29 |
DEL PEAK 17(7Q31.1) WILD-TYPE | 343 | 15 | 56 |
P value = 3.12e-08 (t-test), Q value = 1.3e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 18(7Q36.3) CNV | 50 | 70.8 (8.3) |
DEL PEAK 18(7Q36.3) WILD-TYPE | 403 | 62.7 (11.3) |
P value = 3.54e-16 (Fisher's exact test), Q value = 1.6e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 18(7Q36.3) CNV | 13 | 5 | 32 |
DEL PEAK 18(7Q36.3) WILD-TYPE | 338 | 13 | 53 |
P value = 6.04e-27 (Fisher's exact test), Q value = 2.9e-24
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 19(8P23.2) CNV | 28 | 4 | 55 |
DEL PEAK 19(8P23.2) WILD-TYPE | 323 | 14 | 30 |
P value = 3.04e-11 (Fisher's exact test), Q value = 1.3e-08
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 20(9P23) CNV | 20 | 3 | 30 |
DEL PEAK 20(9P23) WILD-TYPE | 331 | 15 | 55 |
P value = 1.12e-09 (t-test), Q value = 4.7e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 21(9Q34.11) CNV | 104 | 68.8 (8.8) |
DEL PEAK 21(9Q34.11) WILD-TYPE | 349 | 62.1 (11.4) |
P value = 1.16e-17 (Fisher's exact test), Q value = 5.4e-15
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 21(9Q34.11) CNV | 46 | 8 | 50 |
DEL PEAK 21(9Q34.11) WILD-TYPE | 305 | 10 | 35 |
P value = 2.6e-06 (Fisher's exact test), Q value = 0.00099
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 22(10Q23.31) CNV | 28 | 3 | 25 |
DEL PEAK 22(10Q23.31) WILD-TYPE | 323 | 15 | 60 |
P value = 2.53e-08 (t-test), Q value = 1e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 23(11P15.5) CNV | 80 | 69.3 (9.0) |
DEL PEAK 23(11P15.5) WILD-TYPE | 373 | 62.4 (11.3) |
P value = 2.95e-21 (Fisher's exact test), Q value = 1.4e-18
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 23(11P15.5) CNV | 27 | 6 | 47 |
DEL PEAK 23(11P15.5) WILD-TYPE | 324 | 12 | 38 |
P value = 1.32e-05 (t-test), Q value = 0.0049
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 24(11Q14.1) CNV | 54 | 69.1 (8.8) |
DEL PEAK 24(11Q14.1) WILD-TYPE | 399 | 62.9 (11.4) |
P value = 2.57e-15 (Fisher's exact test), Q value = 1.2e-12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 24(11Q14.1) CNV | 16 | 6 | 32 |
DEL PEAK 24(11Q14.1) WILD-TYPE | 335 | 12 | 53 |
P value = 8.1e-05 (t-test), Q value = 0.029
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 25(11Q25) CNV | 72 | 68.2 (10.0) |
DEL PEAK 25(11Q25) WILD-TYPE | 381 | 62.8 (11.3) |
P value = 9.51e-16 (Fisher's exact test), Q value = 4.3e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 25(11Q25) CNV | 27 | 5 | 40 |
DEL PEAK 25(11Q25) WILD-TYPE | 324 | 13 | 45 |
P value = 2.44e-10 (Fisher's exact test), Q value = 1e-07
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 26(12Q23.1) CNV | 10 | 1 | 23 |
DEL PEAK 26(12Q23.1) WILD-TYPE | 341 | 17 | 62 |
P value = 5.99e-05 (t-test), Q value = 0.021
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 27(12Q24.33) CNV | 47 | 69.1 (8.9) |
DEL PEAK 27(12Q24.33) WILD-TYPE | 406 | 63.0 (11.3) |
P value = 1.3e-13 (Fisher's exact test), Q value = 5.7e-11
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 27(12Q24.33) CNV | 15 | 1 | 31 |
DEL PEAK 27(12Q24.33) WILD-TYPE | 336 | 17 | 54 |
P value = 4.54e-10 (Fisher's exact test), Q value = 1.9e-07
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 28(13Q11) CNV | 32 | 3 | 34 |
DEL PEAK 28(13Q11) WILD-TYPE | 319 | 15 | 51 |
P value = 0.000338 (t-test), Q value = 0.12
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 29(13Q14.2) CNV | 74 | 67.5 (9.6) |
DEL PEAK 29(13Q14.2) WILD-TYPE | 379 | 62.9 (11.4) |
P value = 2.96e-05 (Fisher's exact test), Q value = 0.011
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 29(13Q14.2) CNV | 42 | 4 | 28 |
DEL PEAK 29(13Q14.2) WILD-TYPE | 309 | 14 | 57 |
P value = 0.00062 (t-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 30(14Q13.1) CNV | 56 | 68.1 (9.9) |
DEL PEAK 30(14Q13.1) WILD-TYPE | 397 | 63.0 (11.3) |
P value = 1.43e-11 (Fisher's exact test), Q value = 6.1e-09
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 30(14Q13.1) CNV | 21 | 5 | 30 |
DEL PEAK 30(14Q13.1) WILD-TYPE | 330 | 13 | 55 |
P value = 1.36e-08 (t-test), Q value = 5.6e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 31(15Q15.1) CNV | 108 | 68.6 (9.6) |
DEL PEAK 31(15Q15.1) WILD-TYPE | 345 | 62.1 (11.3) |
P value = 4.8e-22 (Fisher's exact test), Q value = 2.3e-19
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 31(15Q15.1) CNV | 45 | 7 | 56 |
DEL PEAK 31(15Q15.1) WILD-TYPE | 306 | 11 | 29 |
P value = 5.94e-06 (t-test), Q value = 0.0022
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 32(15Q23) CNV | 89 | 68.0 (9.5) |
DEL PEAK 32(15Q23) WILD-TYPE | 364 | 62.6 (11.4) |
P value = 6.56e-23 (Fisher's exact test), Q value = 3.1e-20
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 32(15Q23) CNV | 32 | 5 | 52 |
DEL PEAK 32(15Q23) WILD-TYPE | 319 | 13 | 33 |
P value = 2.08e-08 (t-test), Q value = 8.5e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 33(16P13.3) CNV | 66 | 69.5 (8.0) |
DEL PEAK 33(16P13.3) WILD-TYPE | 387 | 62.6 (11.4) |
P value = 2.15e-17 (Fisher's exact test), Q value = 9.9e-15
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 33(16P13.3) CNV | 22 | 4 | 40 |
DEL PEAK 33(16P13.3) WILD-TYPE | 329 | 14 | 45 |
P value = 1.42e-09 (t-test), Q value = 6e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 34(16Q21) CNV | 122 | 68.4 (9.1) |
DEL PEAK 34(16Q21) WILD-TYPE | 331 | 61.9 (11.5) |
P value = 2.86e-23 (Fisher's exact test), Q value = 1.4e-20
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 34(16Q21) CNV | 54 | 7 | 61 |
DEL PEAK 34(16Q21) WILD-TYPE | 297 | 11 | 24 |
P value = 1.11e-08 (t-test), Q value = 4.6e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 35(16Q23.1) CNV | 132 | 68.0 (9.4) |
DEL PEAK 35(16Q23.1) WILD-TYPE | 321 | 61.9 (11.5) |
P value = 6.27e-27 (Fisher's exact test), Q value = 3.1e-24
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 35(16Q23.1) CNV | 59 | 6 | 67 |
DEL PEAK 35(16Q23.1) WILD-TYPE | 292 | 12 | 18 |
P value = 5.79e-05 (t-test), Q value = 0.021
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 36(17P13.3) CNV | 90 | 67.4 (9.1) |
DEL PEAK 36(17P13.3) WILD-TYPE | 363 | 62.7 (11.5) |
P value = 3.99e-19 (Fisher's exact test), Q value = 1.9e-16
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 36(17P13.3) CNV | 35 | 8 | 47 |
DEL PEAK 36(17P13.3) WILD-TYPE | 316 | 10 | 38 |
P value = 1.18e-07 (t-test), Q value = 4.7e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 37(17P12) CNV | 102 | 68.2 (9.0) |
DEL PEAK 37(17P12) WILD-TYPE | 351 | 62.3 (11.5) |
P value = 3.95e-26 (Fisher's exact test), Q value = 1.9e-23
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 37(17P12) CNV | 37 | 8 | 57 |
DEL PEAK 37(17P12) WILD-TYPE | 314 | 10 | 28 |
P value = 1.35e-06 (t-test), Q value = 0.00052
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 38(17P11.2) CNV | 93 | 68.1 (9.1) |
DEL PEAK 38(17P11.2) WILD-TYPE | 360 | 62.5 (11.5) |
P value = 2.11e-19 (Fisher's exact test), Q value = 9.9e-17
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 38(17P11.2) CNV | 37 | 7 | 49 |
DEL PEAK 38(17P11.2) WILD-TYPE | 314 | 11 | 36 |
P value = 5.19e-06 (t-test), Q value = 0.002
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 39(17Q11.2) CNV | 81 | 68.2 (9.2) |
DEL PEAK 39(17Q11.2) WILD-TYPE | 372 | 62.6 (11.4) |
P value = 3.24e-11 (Fisher's exact test), Q value = 1.4e-08
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 39(17Q11.2) CNV | 38 | 5 | 38 |
DEL PEAK 39(17Q11.2) WILD-TYPE | 313 | 13 | 47 |
P value = 4.94e-06 (t-test), Q value = 0.0019
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 40(17Q21.2) CNV | 87 | 68.1 (9.5) |
DEL PEAK 40(17Q21.2) WILD-TYPE | 366 | 62.6 (11.4) |
P value = 1.6e-15 (Fisher's exact test), Q value = 7.2e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 40(17Q21.2) CNV | 37 | 6 | 44 |
DEL PEAK 40(17Q21.2) WILD-TYPE | 314 | 12 | 41 |
P value = 9.72e-15 (Fisher's exact test), Q value = 4.3e-12
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 41(18Q23) CNV | 30 | 5 | 40 |
DEL PEAK 41(18Q23) WILD-TYPE | 321 | 13 | 45 |
P value = 5.7e-12 (t-test), Q value = 2.5e-09
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 42(19P13.3) CNV | 122 | 68.9 (8.7) |
DEL PEAK 42(19P13.3) WILD-TYPE | 331 | 61.7 (11.5) |
P value = 1.55e-49 (Fisher's exact test), Q value = 7.6e-47
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 42(19P13.3) CNV | 36 | 8 | 78 |
DEL PEAK 42(19P13.3) WILD-TYPE | 315 | 10 | 7 |
P value = 4.24e-08 (Fisher's exact test), Q value = 1.7e-05
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 43(19P12) CNV | 15 | 4 | 21 |
DEL PEAK 43(19P12) WILD-TYPE | 336 | 14 | 64 |
P value = 6.17e-16 (Fisher's exact test), Q value = 2.8e-13
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 44(19Q13.43) CNV | 14 | 4 | 33 |
DEL PEAK 44(19Q13.43) WILD-TYPE | 337 | 14 | 52 |
P value = 0.000708 (Fisher's exact test), Q value = 0.24
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 45(20P12.1) CNV | 12 | 2 | 12 |
DEL PEAK 45(20P12.1) WILD-TYPE | 339 | 16 | 73 |
P value = 6.01e-05 (t-test), Q value = 0.021
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 46(22Q11.1) CNV | 69 | 67.9 (8.8) |
DEL PEAK 46(22Q11.1) WILD-TYPE | 384 | 62.9 (11.5) |
P value = 2.23e-06 (Fisher's exact test), Q value = 0.00086
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 46(22Q11.1) CNV | 37 | 3 | 29 |
DEL PEAK 46(22Q11.1) WILD-TYPE | 314 | 15 | 56 |
P value = 4.35e-07 (Fisher's exact test), Q value = 0.00017
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 47(22Q12.1) CNV | 38 | 7 | 28 |
DEL PEAK 47(22Q12.1) WILD-TYPE | 313 | 11 | 57 |
P value = 1.13e-08 (t-test), Q value = 4.7e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 48(22Q13.31) CNV | 104 | 68.7 (9.4) |
DEL PEAK 48(22Q13.31) WILD-TYPE | 349 | 62.1 (11.3) |
P value = 5.4e-19 (Fisher's exact test), Q value = 2.5e-16
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 48(22Q13.31) CNV | 45 | 7 | 52 |
DEL PEAK 48(22Q13.31) WILD-TYPE | 306 | 11 | 33 |
P value = 1.62e-07 (t-test), Q value = 6.4e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 49(22Q13.32) CNV | 109 | 68.3 (10.0) |
DEL PEAK 49(22Q13.32) WILD-TYPE | 344 | 62.2 (11.2) |
P value = 3.49e-19 (Fisher's exact test), Q value = 1.6e-16
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 49(22Q13.32) CNV | 48 | 8 | 53 |
DEL PEAK 49(22Q13.32) WILD-TYPE | 303 | 10 | 32 |
P value = 5.69e-05 (t-test), Q value = 0.02
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 453 | 63.6 (11.2) |
DEL PEAK 50(XP21.1) CNV | 66 | 68.1 (8.9) |
DEL PEAK 50(XP21.1) WILD-TYPE | 387 | 62.9 (11.4) |
P value = 2.97e-14 (Fisher's exact test), Q value = 1.3e-11
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 351 | 18 | 85 |
DEL PEAK 50(XP21.1) CNV | 26 | 2 | 38 |
DEL PEAK 50(XP21.1) WILD-TYPE | 325 | 16 | 47 |
-
Mutation data file = all_lesions.conf_99.cnv.cluster.txt
-
Clinical data file = UCEC-TP.clin.merged.picked.txt
-
Number of patients = 454
-
Number of significantly arm-level cnvs = 98
-
Number of selected clinical features = 5
-
Exclude genes that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene mutations using 't.test' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.